Global Plantar Fasciitis Treatment Market Insights Forecasts to 2033

• The Global Plantar Fasciitis Treatment Market Size was Valued at USD 0.97 Billion in 2023
• The Market Size is Growing at a CAGR of 4.32% from 2023 to 2033
• The Worldwide Plantar Fasciitis Treatment Market Size is Expected to Reach USD 1.48 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Plantar Fasciitis Treatment Market Size is Anticipated to Exceed USD 1.48 Billion by 2033, Growing at a CAGR of 4.32% from 2023 to 2033.

Market Overview

Plantar fasciitis is a painful foot condition resulting from repetitive strain on the plantar fascia, a fibrous band connecting the heel bone to the toes. It stiffens the foot when walking and reinforces the arch. A common condition, it affects around 1 in 10 adults and is more prevalent in those who stand on hard surfaces for extended periods and engage in long-distance running activities. The condition is affected by many factors including age, gender, weight, diabetes, and footwear. It most commonly occurs in women aged 40-60 years, with them being more susceptible. Overweight individuals are at higher risk, while diabetics are more likely to develop the condition. Poor quality footwear can also raise the risk of having a stressed foot. Treatment options for plantar fasciitis include the use of ice, mild painkillers such as paracetamol or ibuprofen, and maintaining fitness through home exercises along with simple leg stretches. As per the data provided by the World Health Organization (WHO), in 2022 one in every eight people globally was obese, with adult obesity having more than doubled since 1990. More than 2.5 billion people and 890 million children were overweight, with 43% of adults aged 18 and 16% living in obesity. Reference

Report Coverage

This research report categorizes the market for the global plantar fasciitis treatment market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global plantar fasciitis treatment market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global plantar fasciitis treatment market.

Driving Factors

Factors driving the plantar fasciitis treatment market include increasing incidences of foot pain, especially in athletes, obese people, and occupations that require prolonged standing. Advancements in treatment options such as extracorporeal shock wave therapy (ESWT), new orthotic devices, and a growing elderly population contribute to the demand for effective treatments. Apart from that, increased participation in sports, sedentary lifestyles, and expanding healthcare facilities in developing regions are fueling the growth of the market.

Restraining Factors

Inhibitory factors in the plantar fasciitis treatment market include the high cost of advanced treatments such as shock wave therapy and surgical interventions, which can be costly for some patients, especially in lower-income regions. The lack of awareness about plantar fasciitis and its treatments among some people is hampering the growth of the market. In addition, access to alternative therapies, such as over-the-counter pain relief and home therapies, may reduce the need for medical interventions.

Market Segmentation

The global plantar fasciitis treatment market share is classified into type, distribution channel, and application.

• The orthotics segment is expected to hold the largest share of the global plantar fasciitis treatment market during the forecast period.   

Based on the type, the global plantar fasciitis treatment market is divided into surgery, orthotics, medication therapy, and others. Among these, the orthotics segment is expected to hold the largest share of the global plantar fasciitis treatment market during the forecast period. The market for orthotic devices is growing due to the increasing demand for non-invasive and cost-effective treatments and increasing awareness of their benefits. Technological advances such as 3D-printed orthotics are increasing the demand for personalized solutions. Long-term orthotic solutions are preferred for the prevention of plantar fasciitis, providing continued support and pain relief.

• The online pharmacy segment is expected to grow at the fastest CAGR in the global plantar fasciitis treatment market during the forecast period.   

Based on the distribution channel, the global plantar fasciitis treatment market is divided into retail pharmacies, online pharmacies, hospital pharmacies, and footwear specialty stores. Among these, the online pharmacy segment is expected to grow at the fastest CAGR in the global plantar fasciitis treatment market during the forecast period. The segment will witness significant growth due to the increasing trend toward e-commerce for healthcare products. Consumers prioritize convenience, availability, and price comparison while purchasing products online. Also, online platforms facilitate a wide range of treatment options that include medications, orthotics, and therapeutic footwear.

• The clinics segment is expected to grow at the fastest CAGR in the global plantar fasciitis treatment market during the forecast period.   

Based on the application, the global plantar fasciitis treatment market is divided into hospitals, clinics, and others. Among these, the clinics segment is expected to grow at the fastest CAGR in the global plantar fasciitis treatment market during the forecast period. This segment is expected to witness significant growth in the plantar fasciitis treatment market in the coming years due to the increasing number of specialty clinics including orthopedic podiatry centers, offering targeted treatments for various conditions related to the feet such as plantar fasciitis. These clinics offer personalized care with specialized equipment favoring focused, non-invasive treatment.

Regional Segment Analysis of the Global Plantar Fasciitis Treatment Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global plantar fasciitis treatment market over the predicted timeframe.

North America is anticipated to hold the largest share of the global plantar fasciitis treatment market over the predicted timeframe. The region’s foot-related conditions dominate due to lifestyle factors like obesity, sports participation, and the aging population. The U.S. is home to one of the advanced healthcare infrastructures, specialized treatment options, and innovative therapies. High healthcare expenditure and insurance coverage support the demand for non-invasive and surgical treatments. The presence of leading medical device manufacturers and pharmaceutical companies also contributes to the market share.

Asia Pacific is expected to grow at the fastest pace in the global plantar fasciitis treatment market during the forecast period. The region is experiencing rapid growth in the adoption of non-invasive and invasive plantar fasciitis treatments due to factors such as increased foot health awareness, obesity and diabetes prevalence, and demand for advanced medical treatments. Expanding healthcare infrastructure and disposable income in emerging economies are enabling more patients to access specialized treatments, including orthotics, shockwave therapy, and advanced surgical options.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global plantar fasciitis treatment market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bayer AG 
• Pfizer Inc. 
• Sanofi S.A. 
• Superfeet Worldwide Inc. 
• Algeo Limited 
• Orthofeet Inc. 
• Breg Inc. 
• DJO Global Inc. 
• Zoll Medical Corporation 
• Footlogics 
• Wright Medical Group N.V. 
• Arthrex Inc. 
• Hanger Inc. 
• Darco International Inc. 
• Implus Footcare LLC
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2022, Atlecko introduced a 12-piece plantar fasciitis sock set. These compression socks are scientifically developed to help reduce discomfort caused by plantar fasciitis.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global plantar fasciitis treatment market based on the below-mentioned segments: 

Global Plantar Fasciitis Treatment Market, By Type

• Surgery
• Orthotics
• Medication Therapy
• Others

Global Plantar Fasciitis Treatment Market, By Distribution Channel

• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies
• Footwear Specialty Stores

Global Plantar Fasciitis Treatment Market, By Application

• Hospitals
• Clinics
• Others

Global Plantar Fasciitis Treatment Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa